SHARPE
Reported results
- Sales were $2.91 billion
- GAAP net loss attributable to Dauch was $(45.3) million, or (1.6)% of sales
- GAAP diluted loss per share was $(0.19)
- Non-GAAP Adjusted EBITDA was $358.5 million, or 12.3% of sales
- Non-GAAP Adjusted earnings per share was $0.22
- GAAP net cash provided by operating activities was $150.1 million
- Non-GAAP Adjusted free cash flow was $126.7 million
Guidance
- Full year 2026 sales are expected to be in the range of $10.8 - $10.875 billion
- Full year 2026 targeted non-GAAP Adjusted EBITDA is expected to be in the range of $1.35 - $1.375 billion
- Full year 2026 targeted non-GAAP Adjusted free cash flow is expected to be in the range of $270 - $310 million
- Full year 2026 restructuring cash payments are expected to be $135 - $150 million
- Full year 2026 synergy implementation cash payments are expected to be $85 - $100 million
Notes
Amounts for prior periods were recast under revised definitions for non-GAAP Adjusted EBITDA and non-GAAP Adjusted earnings per share. Results for 2026 include contributions from the acquisition of Dowlais Group plc closed on February 3, 2026.
Price and volatility reaction
The stock moved +2.3% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +3.0 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 4.42 | 2026-11-05 |
| Close after release | 4.52 | 2026-11-06 |
| Realised move | +2.3% | close to close |
| 30d ATM IV change | +3.0 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-06 (8-K, Item 2.02). Read the original filing on sec.gov.